INmune Bio, Inc.
INMB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42 | -$30 | -$27 | -$30 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $7 | $7 | $5 |
| Change in WC | $1 | $10 | -$3 | -$3 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$33 | -$12 | -$23 | -$29 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$15 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$15 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10 | -$5 | $0 | $15 |
| Stock Issued | $28 | $1 | $1 | $80 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1 |
| Financing Cash Flow | $18 | -$4 | $1 | $96 |
| Forex Effect | $0 | -$0 | -$1 | -$0 |
| Net Chg. in Cash | -$15 | -$16 | -$23 | $53 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $36 | $52 | $75 | $22 |
| End Cash | $21 | $36 | $52 | $75 |
| Free Cash Flow | -$33 | -$12 | -$23 | -$44 |